WHC is still in active development. Read this to understand our approach.
depiction of OWQIUQKMMPDHQQ-UHFFFAOYSA-N.svg
isomerdesign

Dimethocaine

Check on isomerdesign

wiki

Dimethocaine

Check on wiki

Data

InChI: InChI=1S/C16H26N2O2/c1-5-18(6-2)11-16(3,4)12-20-15(19)13-7-9-14(17)10-8-13/h7-10H,5-6,11-12,17H2,1-4H3

Synonyms: 1-Propanol,2-dimethyl-, 4-aminobenzoate (ester),3-Diethylamino-2,2-dimethylpropyl 4-Aminobenzoate,SCHEMBL25088,DIMETHOCAINE [MI],UNII-R3L4A6GOWZ,Dimethocaine,WLN: ZR DVO1X1&1&1N2&2,DTXSID40240185,4-Aminobenzoic Acid 3-Diethylamino-2,2-dimethylpropyl Ester,1-Propanol, 3-(diethylamino)-2,2-dimethyl-, p-aminobenzoate (ester),1-Propanol,2-dimethyl-, p-aminobenzoate (ester),1-Propanol, 3-(diethylamino)-2,2-dimethyl-, p-aminobenzoate,[3-(diethylamino)-2,2-dimethylpropyl] 4-aminobenzoate,CHEMBL4752832,NSC-68927,1-Propanol, 3-(diethylamino)-2,2-dimethyl-, 4-aminobenzoate (ester),(3-Diethylamino-2,2-dimethylpropyl)-4-amino benzoate,F12666,3-(Diethylamino)-2,2-dimethylpropyl 4-aminobenzoate,HY-121870,NSC 68927,CHEBI:135154,3-(Dimethylamino)-2,2-dimethyl-1-propanol p-aminobenzoate,Q3827109,4-Aminobenzoesaeure-3-diethylamino-2,2-dimethylproplylester,1-propanol,2-((diethylamino)methyl)-2-methyl-,1-(4-aminobenzoate),CS-0083580,BCP21170,(3-Diethylamino-2,2-dimethyl)propyl 4-aminobenzoat,Larocaine,D4179,R3L4A6GOWZ,1-Propanol, 2-[(diethylamino)methyl]-2-methyl-, 1-(4-aminobenzoate),1-Propanol,2-[(diethylamino)methyl]-2-methyl-, 1-(4-aminobenzoate),NSC68927,94-15-5,AMY16056,MFCD01697030,BRN 2215967,DMC,DS-16345,A844843,3-(Diethylamino)-2,2-dimethylpropyl 4-aminobenzoate #,1-Propanol,2-dimethyl-, p-aminobenzoate,ZINC1695364,DIMETHOCAINE [WHO-DD]

Market name: dimethocaine

Estimated data

Solubility: -2.554 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 71.0% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.